1-(aminomethyl)cyclopentane carboxylic acid | 102074-43-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-(aminomethyl)cyclopentane carboxylic acid
• 英文别名: 1-(Azaniumylmethyl)cyclopentane-1-carboxylate
• CAS: 102074-43-1
• 化学式: C₇H₁₃NO₂
• mdl: MFCD09971199
• 分子量: 143.186
• InChiKey: VZQSZPCSJJSCDJ-UHFFFAOYSA-N

物化性质

• 沸点：
  276.8±13.0 °C(Predicted)
• 密度：
  1.153±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  67.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(aminomethyl)cyclopentane carboxylic acid 在 氢溴酸 、 溶剂黄146 、 sodium hydroxide 作用下， 以 水 为溶剂， 反应 4.5h， 生成 1-((methylamino)methyl)cyclopentanecarboxylic acid hydrobromide
  参考文献：
  名称：

  [EN] SGC STIMULATORS
  [FR] STIMULATEURS DE SGC

  摘要：

  公开号：

  WO2014144100A3
• 作为产物：
  描述：

  1-氰基环戊烷羧酸甲酯 在 镍 sodium hydroxide 、 氢气 作用下， 以 甲醇 为溶剂， 40.0 ℃ 、400.0 kPa 条件下， 反应 27.0h， 生成 1-(aminomethyl)cyclopentane carboxylic acid
  参考文献：
  名称：

  Preparation and Structure ofβ-Peptides Consisting of Geminally Disubstitutedβ2,2- andβ3,3-Amino Acids: A Turn Motif forβ-Peptides

  摘要：

  We report on the synthesis of new and previously described beta-peptides (1-6), consisting of up to twelve beta(2,2-) or beta(3,3)-geminally disubstituted beta-amino acids which do not fit into any of the secondary structural patterns of beta-peptides, hitherto disclosed. The required 2,2- and 3,3-dimethyl derivatives of 3-aminopropanoic acid are readily obtained from 3-methylbut-2-enoic acid and ammonia (Scheme 1) and from Boc-protected methyl 3-aminopropanoate by enolate methylation (Scheme 2). Protected (Boc for solution-, Fmoc for solid-phase syntheses) 1-(aminomethyl)cycloalkanecarboxylic-acid derivatives (with cyclopropane, cyclobutane, cyclopentane, and cyclohexane rings) are obtained from 1-cyanocycloalkanecarboxylates and the corresponding dihaloalkanes (Scheme 3). Fully C-13- and N-15-labeled 3-amino-2,2-dimethylpropanoic-acid derivatives were prepared from the corresponding labeled precursors (see asterixed formula numbers and Scheme 4). Coupling of these amino acids was achieved by methods which we had previously employed for other beta-peptide syntheses ( intermediates 18 - 23). Crystal structures of Boc-protected geminally disubstituted amine acids (16a-d) and of the corresponding tripeptide (23a), as well as NMR and IR spectra of an isotopically labeled beta-hexapeptide (2a*) are presented (Figs. 1-4) and discussed. The tripeptide structure contains a ten-membered H-bonded ring which is proposed to be a turn-forming motif for beta-peptides (Fig. 2).

  DOI：

  10.1002/(sici)1522-2675(19981216)81:12<2218::aid-hlca2218>3.0.co;2-0

文献信息

• TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR
  申请人：Seikagaku Corporation

  公开号：US20200138964A1

  公开（公告）日：2020-05-07

  Provided is a compound obtained by conjugating a tertiary amine compound or imine compound, which is useful as a drug, with a polymer, in which a structure D + having a quaternary ammonium salt or iminium salt formed from a tertiary amine compound or imine compound D and a polymer residue Poly having a carboxy group are bonded to each other via a structure —C(R 1 )(R 2 )OC(O)ANHC(═O)—.

  提供的是一种化合物，通过将一种三级胺化合物或亚胺化合物与聚合物共轭，用作药物，其中具有由三级胺化合物或亚胺化合物D形成的季铵盐或亚胺盐的结构D + 和具有羧基的聚合物残基Poly通过结构—C(R 1 )(R 2 )OC(O)ANHC(═O)—相互键合。
• [EN] SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS<br/>[FR] COMPOSES CYCLOPENTANE SUBSTITUES CONVENANT COMME INHIBITEURS DES NEURAMINIDASES
  申请人：BIOCRYST PHARMACEUTICALS, INC.

  公开号：WO1997047194A1

  公开（公告）日：1997-12-18

  (EN) Compounds represented by formula (I), and pharmaceutically acceptacle salts thereof; and their method of preparation are provided. Compounds of the above formula are influenza virus neuraminidase inhibitors and can be used in treating patients infected with influenza virus.(FR) La présente invention concerne des composés représentés par la formule générale (I) ainsi que certains de leurs sels admis en pharmacie. L'invention concerne également les procédés d'élaboration correspondants. Les composés dérivés de la formule générale (I) étant des inhibiteurs des neuraminidases du virus de la grippe, il conviennent particulièrement au traitement des patients infectés par le virus de la grippe.

  化合物式（I）及其药学上可接受的盐以及其制备方法。上述化合物是流感病毒神经氨酸酶抑制剂，可用于治疗感染流感病毒的患者。
• sGC STIMULATORS
  申请人：IRONWOOD PHARMACEUTICALS, INC.

  公开号：US20160031903A1

  公开（公告）日：2016-02-04

  Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

  本文描述了化学式I'和I的化合物，它们可用作sGC的刺激剂，特别是NO独立，血红素依赖性的刺激剂。这些化合物还可用于治疗、预防或管理本文中披露的各种疾病。
• sGC stimulators
  申请人：Ironwood Pharmaceuticals, Inc.

  公开号：US10183021B2

  公开（公告）日：2019-01-22

  Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

  本文描述了式 I′ 和 I 的化合物，它们可用作 sGC 的刺激剂，特别是 NO 依赖性、血红素依赖性刺激剂。这些化合物还可用于治疗、预防或控制本文公开的各种疾病。
• Testa,E. et al., Justus Liebigs Annalen der Chemie, 1961, vol. 639, p. 166 - 180
  作者：Testa,E. et al.

  DOI：——

  日期：——